TGA / PMDA / NMPA · Asia-Pacific
fluocinolone — TGA / PMDA / NMPA regulatory status
fluocinolone regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 3
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 6 published clinical programs and 0 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| fluocinolone acetonide | Phase 3 | ANI PHARMACEUTICALS | NCT00344968, NCT00490815 |
| 0.59 mg fluocinolone acetonide intravitreal implant | Phase 2 | Bausch + Lomb | NCT00576459 |
| Fluocinolone Acetonide | Phase 2 | ANI PHARMACEUTICALS | NCT00695318 |
| Fluocinolone Acetonide | Phase 2 | ANI PHARMACEUTICALS | NCT00770770 |
| Fluocinolone Acetonide Intravitreal Implant 0.18 mg | Approved | ANI PHARMACEUTICALS | NCT05322070 |
| fluocinolone acetonide 190 micrograms | Approved | ANI PHARMACEUTICALS | NCT06539481 |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of fluocinolone?
fluocinolone currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get fluocinolone regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to fluocinolone?
This spoke lists 6 published programs associated with fluocinolone in our pipeline index.